José Gerardo González-González Selected Research

José Gerardo González-González Research Topics

Disease

5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2017
4	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2020 - 01/2014
3	Insulin Resistance 01/2020 - 03/2017
3	Hyperglycemia 10/2017 - 01/2014
2	Hypothyroidism 11/2021 - 01/2014
2	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 10/2017
2	Acanthosis Nigricans 12/2019 - 01/2018
2	Obesity 01/2018 - 10/2009
2	Acidosis 08/2015 - 01/2014
2	Pancreatitis 05/2015 - 01/2014
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 05/2015 - 01/2014
1	Pheochromocytoma 11/2021
1	Paraganglioma (Paragangliomas) 11/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Fatigue 11/2021
1	Dementia (Dementias) 01/2021
1	Cognitive Dysfunction 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2020
1	Hypopituitarism (Sheehan's Syndrome) 01/2018
1	Heart Failure 10/2017
1	Left Ventricular Dysfunction 10/2017
1	Diabetic Cardiomyopathies 10/2017
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2017
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 01/2017
1	Osteomalacia 08/2016
1	Chronic Disease (Chronic Diseases) 01/2016
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2016
1	Paralysis (Palsy) 08/2015
1	Diabetes Mellitus 05/2015
1	Hypercalcemia (Milk Alkali Syndrome) 04/2014
1	Seminoma 04/2014
1	Vitiligo 04/2014
1	Hyperandrogenism 01/2014
1	Hyperamylasemia 01/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2014
1	Ketosis 01/2014
1	Substance-Related Disorders (Drug Abuse) 06/2012
1	Alopecia (Baldness) 10/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2009

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2009
7	Insulin (Novolin)FDA Link 01/2020 - 10/2009
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2017
3	Triglycerides (Triacylglycerol)IBA 12/2020 - 05/2015
3	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2020 - 04/2014
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2017
2	Hormones (Hormone)IBA 01/2020 - 08/2016
2	TolueneIBA 08/2015 - 06/2012
2	SteroidsIBA 07/2015 - 04/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2015 - 04/2014
2	GlucocorticoidsIBA 07/2015 - 01/2014
1	CatecholaminesIBA 11/2021
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 11/2021
1	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2021
1	SodiumIBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2020
1	AntibodiesIBA 01/2018
1	Isophane Insulin (NPH Insulin)FDA Link 10/2017
1	Protamines (Protamine Sulfate)FDA Link 10/2017
1	Galectin 3 (LGALS3)IBA 10/2017
1	Fibroblast Growth Factor-23IBA 08/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Parathyroid Hormone-Related ProteinIBA 04/2014
1	1,25-dihydroxyvitamin DIBA 04/2014
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 04/2014
1	Prednisone (Sone)FDA LinkGeneric 01/2014
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2014
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 01/2014
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2014
1	Asparaginase (Elspar)FDA Link 01/2014
1	Vincristine (Oncovin)FDA LinkGeneric 01/2014
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2014
1	AndrogensIBA 10/2009
1	Testosterone (Sustanon)FDA Link 10/2009
1	LipidsIBA 10/2009

Therapy/Procedure

4	Therapeutics 11/2021 - 01/2014
2	Glycemic Control 10/2017 - 05/2015
1	Aftercare (After-Treatment) 04/2014
1	Drug Therapy (Chemotherapy) 01/2014
1	Remission Induction 01/2014